May 14, 2020 / 8:44 PM / 12 days ago

BRIEF-Acer Therapeutics Reports Q1 Loss Per Share Of $0.49

May 14 (Reuters) - Acer Therapeutics Inc:

* ACER THERAPEUTICS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* Q1 LOSS PER SHARE $0.49

* Q1 EARNINGS PER SHARE ESTIMATE $-0.40 — REFINITIV IBES DATA

* ENDED Q1 WITH $7.0 MILLION IN CASH AND CASH EQUIVALENTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below